Emergent Biosolutions
- All
- News
'Emergent Biosolutions' - 1 News Result(s)
-
US Company Signs $87 Million Coronavirus Vaccine Deal With UK Pharma Firm
Emergent BioSolutions Inc said on Thursday it signed an $87 million deal to make AstraZeneca Plc's experimental COVID-19 vaccine in the United States, boosting the British drugmaker's efforts to bring a vaccine to the market.
'Emergent Biosolutions' - 1 News Result(s)
-
US Company Signs $87 Million Coronavirus Vaccine Deal With UK Pharma Firm
Emergent BioSolutions Inc said on Thursday it signed an $87 million deal to make AstraZeneca Plc's experimental COVID-19 vaccine in the United States, boosting the British drugmaker's efforts to bring a vaccine to the market.
